Press release
Enzyme Replacement Therapy Market Set To Surge Due To Escalating Prevalence Of Chronic And Inherited Disorders: The Driving Engine Behind Enzyme Replacement Therapy Market Evolution in 2025
Enzyme Replacement Therapy
Enzyme Replacement Therapy Market Size Growth Forecast: What to Expect by 2025?
The market for enzyme replacement therapy has seen significant expansion over the past few years. The size of the market is projected to increase from $11.58 billion in 2024 to $12.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.8%. Factors that have contributed to the growth in the past include breakthroughs in early therapeutic discoveries, approvals for cutting-edge treatments, aggregated knowledge about diseases, favorable outcomes in clinical trials, and incentives and support from regulatory bodies.
How Will the Enzyme Replacement Therapy Market Size Evolve and Grow by 2029?
There is an anticipated significant expansion in the enzyme replacement therapy market in the coming years, with forecasts predicting it will reach "$17.81 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.3%. Factors like enhanced patient access to healthcare services, customized therapies and personal medicine, alterations in the regulatory framework, and heightened awareness among the patient population are contributing to this predicted growth. The forthcoming period will also witness key trends such as the incorporation of digital health, emphasis on solutions centered around the patient, novel biomarker research, and the implementation of precision medicine.
View the full report here:
https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report
What Drivers Are Propelling the Growth of Enzyme Replacement Therapy Market Forward?
The enzyme replacement therapy market is anticipated to expand due to the increasing occurrence of rare, chronic, and inherited diseases. Chronic illnesses are conditions that persist for longer than three months and often worsen over time. These illnesses are particularly common among the elderly population and they are often manageable, but not curable. The American Lung Association, a nonprofit organization based in the US, reported in July 2024 that in 2022, 44.2 million Americans, representing 13.5% of the population, had been medically diagnosed with asthma; this indicates an increase from the 12.9% reported in 2021. As such, the higher occurrence of rare, chronic, and inherited diseases is projected to stimulate the expansion of the enzyme replacement therapy market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample_request?id=10512&type=smp
Which Emerging Trends Are Transforming the Enzyme Replacement Therapy Market in 2025?
The primary trend within the enzyme replacement therapy market is product approvals. Numerous therapies have received market authorization, reflecting the increased acceptance and growing popularity of these treatments. For example, in February 2023, Lamzede (velmanase alfa) was approved by the Food and Drug Administration (FDA), an American federal health department entity. This was a landmark moment because it was the country's first authorized enzyme replacement therapy for non-central neurological indications of alpha-mannosidosis, a rare genetic disorder marked by the lack of an alpha-mannosidase enzyme. Lamzede enhances normal cellular activities in patients by mimicking the function of the absent enzyme. It is usually administered as a 10mg injection once a week, aiding in healthy cellular functioning.
What Are the Key Segments in the Enzyme Replacement Therapy Market?
The enzyme replacement therapy market covered in this report is segmented -
1) By Enzyme Type: Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types
2) By Route Of Administration: Oral, Parenteral
3) By Application: Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications
4) By End-Users: Hospitals, Infusion Centers, Other End-Users
Subsegments:
1) By Agalsidase Alfa: Fabry Disease Treatment
2) By Agalsidase Beta: Fabry Disease Treatment
3) By Galsulfase: Mucopolysaccharidosis VI (MPS VI) Treatment
4) By Other Enzyme Types: Alglucosidase Alfa, Idursulfase, Velaglucerase Alfa
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/Customise?id=10512&type=smp
Who Are the Key Players Shaping the Enzyme Replacement Therapy Market's Competitive Landscape?
Major companies operating in the enzyme replacement therapy market include Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Johnson & Johnson Services Inc., Alexion Pharmaceuticals Inc., Recordati Rare Diseases Inc., Sangamo Therapeutics Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc.
What Geographic Markets Are Powering Growth in the Enzyme Replacement Therapy Market?
North America was the largest region in the enzyme replacement therapy market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10512
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enzyme Replacement Therapy Market Set To Surge Due To Escalating Prevalence Of Chronic And Inherited Disorders: The Driving Engine Behind Enzyme Replacement Therapy Market Evolution in 2025 here
News-ID: 4095646 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Enzyme
Enzyme Replacement Therapy Market: Advancing Treatment for Inherited Enzyme Defi …
The Enzyme Replacement Therapy Market at a global level was worth USD 10.1 Billion in 2022 and is anticipated to expand to USD 20.6 Billion by 2032, experiencing a CAGR of 7.6% during the forecast period of 2023-2032.
The Enzyme Replacement Therapy (ERT) Market stands at the forefront of medical innovation, offering transformative treatment options for individuals with inherited enzyme deficiencies. Enzyme replacement therapy involves the infusion of artificial enzymes into…
Anti-Inflammatory Activity Enzyme and Protease Enzyme | Pearlzyme Inc
Pearlzyme Inc. focuses on boosting animal immune systems against infection and increasing milk lactation with anti-inflammatory activity enzymes. Also enzyme feed additives demonstrates a commitment to improving animal health and productivity. By developing innovative products, the company aims to provide effective solutions to its customers.
Pearlzyme Inc is committed to sustainable development and reducing environmental impact. As an environmentally conscious company, it recognizes the importance of minimizing its footprint and contributing…
Meat Tenderizing Agents Market 2018 Flourishes with International Prestigious Pl …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Meat Tenderizing Agents Market 2018 Flourishes with International Prestigious Pl …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Meat Tenderizing Agents Market Global Leader | Enzyme Bioscience Pvt. Ltd, AB En …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Enzymes in Biofuel Market Research Report 2018 | Biofuel Enzyme, Schaumann Bioen …
Researchmoz added Most up-to-date research on "Global Enzymes in Biofuel Market Research Report 2018" to its huge collection of research reports.
This report studies the global Enzymes in Biofuel market status and forecast, categorizes the global Enzymes in Biofuel market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
The…
